The goal of the Interdepartmental Training Program in Cellular and Molecular Endocrinology at Johns Hopkins is to train physicians and postdoctoral fellows in biomedical science related to endocrinology and endocrine disease. The Program Director will work with a Steering Committee to choose candidates from two pools of highly talented individuals: 1) endocrine fellows at Johns Hopkins who have completed one year of clinical endocrine training, and 2) M.D. and Ph.D. applicants from this and other institutions who have a strong interest in fundamental laboratory training. Selection will be based not only on an individual's qualifications and interests, but also on their potential and commitment to applying fundamental science to clinical problems. The training program consists of at least two years of intensive basic science laboratory work under the direction of sixteen preceptors whose interests fall within the broad concepts of molecular and cellular biology, membrane protein biochemistry, genetics, cellular physiology, and developmental biology. Trainees will learn and use laboratory techniques including recombinant DNA and RNA manipulations, transgenic technology, protein biochemistry, electrophysiology, cell and tissue culture, and immunology as applied endocrine problems. In addition to basic laboratory work, trainees will participate in a curriculum that consists of research seminars, journal club, clinical conferences, and formal courses to be selected by mutual decision between the trainee, the preceptor, and the Program Director. The clinical experience is limited to 2 to 4 half-day sessions per month in an Outpatient Endocrine Clinic. The availability of an NIH-funded General Clinical Research Center provides trainees with an opportunity to develop clinical research protocols that complement their laboratory studies, and to discover the potential benefits of translational research. The major goal of this program is to train academic endocrinologists who function as independent laboratory scientists capable of developing hypotheses and creating research plans that address contemporary endocrine problems. M.D. candidates are eligible to sit for the Endocrine or Pediatric Endocrinology subspecialty boards.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007751-10
Application #
7120482
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Hyde, James F
Project Start
1997-09-12
Project End
2007-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
10
Fiscal Year
2006
Total Cost
$283,249
Indirect Cost
Name
Johns Hopkins University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Zheng, Liwei; Cao, Yong; Ni, Shuangfei et al. (2018) Ciliary parathyroid hormone signaling activates transforming growth factor-? to maintain intervertebral disc homeostasis during aging. Bone Res 6:21
Pilla, Scott J; Dotimas, James R; Maruthur, Nisa M et al. (2018) Changes in metformin use and other antihyperglycemic therapies after insulin initiation in patients with type 2 diabetes. Diabetes Res Clin Pract 139:221-229
Qiu, Shuiqing; Vazquez, Juliana Torrens; Boulger, Erin et al. (2017) Hepatic estrogen receptor ? is critical for regulation of gluconeogenesis and lipid metabolism in males. Sci Rep 7:1661
Cao, Yong; Liao, Shenghui; Zeng, Hao et al. (2017) 3D characterization of morphological changes in the intervertebral disc and endplate during aging: A propagation phase contrast synchrotron micro-tomography study. Sci Rep 7:43094
Andrisse, Stanley; Childress, Shameka; Ma, Yaping et al. (2017) Low-Dose Dihydrotestosterone Drives Metabolic Dysfunction via Cytosolic and Nuclear Hepatic Androgen Receptor Mechanisms. Endocrinology 158:531-544
Wang, Long; Xie, Liang; Tintani, Francis et al. (2017) Aberrant Transforming Growth Factor-? Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia. Stem Cells Transl Med 6:394-404
Xie, Liang; Tintani, Francis; Wang, Xiao et al. (2016) Systemic neutralization of TGF-? attenuates osteoarthritis. Ann N Y Acad Sci 1376:53-64
Mathioudakis, Nestoras; Sundaresh, Ram; Larsen, Alexandra et al. (2015) Expression of the pituitary stem/progenitor marker GFR?2 in human pituitary adenomas and normal pituitary. Pituitary 18:31-41
Wolf, Risa M; Steele, Kimberley E; Peterson, Leigh A et al. (2015) Lower Circulating C1q/TNF-Related Protein-3 (CTRP3) Levels Are Associated with Obesity: A Cross-Sectional Study. PLoS One 10:e0133955
Salehi, Sajad; Adeshina, Ikeoluwa; Chen, Haolin et al. (2015) Developmental and endocrine regulation of kisspeptin expression in mouse Leydig cells. Endocrinology 156:1514-22

Showing the most recent 10 out of 60 publications